| 中华人民共和国卫生部. 2010中国卫生统计年鉴[M/OL]. 北京:中国协和医科大学出版社, 2010[2012-10-25]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/index.htm. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352:1685-1695. Gasbarrini G, Racco S, Franceschi F, et al. Helicobacter pylori infection:from gastric to systemic disease[J]. Recenti Prog Med, 2010, 101:27-33. Farsak B, Yildirir A, Akyön Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR[J]. J Clin Microbiol, 2000, 38:4408-4411. Kowalski M. Helicobacter pylori(H. pylori) infection in coronary artery disease:influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary ngioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque[J]. J Physiol Pharmacol, 2001, 52:3-31. Elkind MS, Luna JM, Moon YP, et al. Infectious burden and carotid plaque thickness:the Northern Manhattan study[J]. Stroke, 2010, 41:e117-e122. Sawayama Y, Ariyama I, Hamada M, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke:Fukuoka Harasanshin Atherosclerosis Trial(FHAT)[J]. Atherosclerosis, 2005, 178:303-309. Ro?ankovi PB, Huzjan AL, Cupi H, et al. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease[J]. J Neurol, 2011, 258:753-761. 陶珍, 曲乐丰, 丁素菊, 等. 颈动脉粥样硬化斑块内幽门螺杆菌-细胞毒素相关蛋白A-IgG抗体的表达与颈动脉粥样硬化性脑梗死的关系[J]. 上海医学, 2009, 4:296-298. 陶珍, 曲乐丰, 丁素菊, 等. 幽门螺杆菌感染致兔颈动脉粥样硬化模型的建立[J]. 第二军医大学学报, 2010, 31:37-41. El-Mashad N, El-Emshaty WM, Arfat MS, et al. Relation of Cag-A-positive Helicobacter pylori strain and some inflammatory markers in patients with ischemic heart diseases[J]. Egypt J Immunol, 2009, 16:39-47.Kebapcilar L, Bilgir O, Cetinkaya E, et al. The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels[J]. Clinics(Sao Paulo), 2010, 65:799-802.Laurila A, Bloigu A, Näyhä S, et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 1997, 17:2910-2913. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease[J]. Heart, 1997, 78:273-277. Adiloglu AK, Can R, Nazli C, et al. Ectasia and severe atherosclerosis:relationships with Chlamydia pneumoniae, Helicobacter pylori, and inflammatory markers[J]. Tex Heart Inst J, 2005, 32:21-27. Hamed SA, Amine NF, Galal GM, et al. Vascular risks and complications in diabetes mellitus:the role of Helicobacter pylori infection[J]. J Stroke Cerebrovasc Dis, 2008, 17:86-94. Wang CA, Liu YC, Du SY, et al. Helicobacter pylori neutrophil-activating protein promotes myeloperoxidase release from human neutrophils[J]. Biochem Biophys Res Commun, 2008, 377:52-56.Nazligul Y, Aslan M, Horoz M, et al. The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected[J]. Clin Biochem, 2011, 44:647-649. Ayub A, Mackness MI, Arrol S, et al. Serum paraoxonase after myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 1999, 19:330-335. Aslan M, Nazligul Y, Horoz M, et al. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects[J]. Atherosclerosis, 2008, 196:270-274.Akbas HS, Basyigit S, Suleymanlar I, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects[J]. Lipids Health Dis, 2010, 9:92. Sabine IW, Charlotte L. ICAM-1:Contribution to Vascular Inflammation and Early Atherosclerosis[M]//Angelo S. Coronary Artery Disease-New Insights and Novel Approaches. Croatia:InTech, 2012:65-90. Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects[J]. J Am Coll Cardiol, 2005, 45:1219-1222. Ameriso SF, Fridman EA, Leiguarda RC, et al. Detection of Helicobacter pylori in human carotid atherosclerotic plaques[J]. Stroke, 2001, 3:385-391.Nicholls SJ, Wang Z, Koeth R, et al. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction[J]. Circulation, 2007, 116:2315-2324.Marra M, Bonfigli AR, Bonazzi P, et al. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects[J]. Helicobacter, 2005, 10:609-614. Aydemir S, Eren H, Tekin IO, et al. Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels[J]. Mediators Inflamm, 2010, 2010:685903. Ayada K, Yokota K, Hirai K, et al. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis[J]. Lupus, 2009, 18:1154-1168. Lenzi C, Palazzuoli A, Giordano N, et al. H. pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease[J]. World J Gastroenterol, 2006, 12:7815-7820.Zhu J, Quyyumi AA, Rott D, et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease:evidence for an autoimmue component of atherogensis[J]. Circulation, 2001, 103:1071-1075 |
